Free Trial
NASDAQ:BIS

ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News

$15.94 +0.05 (+0.31%)
Closing price 08/7/2025 03:59 PM Eastern
Extended Trading
$15.63 -0.31 (-1.94%)
As of 07:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

Key Stats

Today's Range
$15.85
$16.16
50-Day Range
$15.08
$18.98
52-Week Range
$14.05
$25.87
Volume
15,938 shs
Average Volume
11,753 shs
Market Capitalization
$2.71 million
Assets Under Management
$2.72 million
Dividend Yield
3.70%
Net Expense Ratio
0.95%
Aggregate Rating
N/A

ETF Overview

ProShares UltraShort Nasdaq Biotechnology Expenses

TypeBISHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.56%0.56%0.54%0.53%
Other Expenses1.67%0.47%0.56%0.52%0.56%
Total Expense2.42%0.75%0.76%0.73%0.73%
Fee Waiver-1.47%-0.67%-0.66%-0.50%-0.63%
Net Expense0.95%0.60%0.63%0.63%0.60%
Receive BIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

BIS ETF News Headlines

Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.
BIS ProShares UltraShort Nasdaq Biotechnology ETF
See More Headlines

BIS ETF - Frequently Asked Questions

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.19 at the beginning of 2025. Since then, BIS stock has decreased by 12.4% and is now trading at $15.94.

Shares of ProShares UltraShort Nasdaq Biotechnology reverse split before market open on Tuesday, August 18th 2020.The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraShort Nasdaq Biotechnology investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Sanofi (SNY), Intel (INTC), Meta Platforms (META), NVIDIA (NVDA) and Advanced Micro Devices (AMD).

Fund Details

Issuer
ProShares
Fund Name
ProShares UltraShort Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:BIS
Inception Date
4/6/2010
Fund Manager
Michael Neches, Tarak Dave

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Biotechnology Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
17

Fund Statistics

Assets Under Management
$2.72 million
Average Daily Volume
$12.12 thousand
Discount/Premium
-0.02%
Leveraged
-2.00

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors, LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
J.P. Morgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
1
Put Options
1
Call Options
1
Short Interest
9,200 shs

Miscellaneous

Beta
-1.41
Creation Unit
50,000
Creation Fee
$250.00
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Top 6 BIS Holdings

  • NET OTHER ASSETS (LIABILITIES)
    Holding Weight: 0.00%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA
    Holding Weight: -26.93%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG
    Holding Weight: -31.13%
  • NASDAQ BIO INDEX SWAP BNP PARIBAS
    Holding Weight: -37.77%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE
    Holding Weight: -38.47%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA
    Holding Weight: -66.10%

This page (NASDAQ:BIS) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners